DMD03

General

Cell Line

hPSCreg name MUNIi003-A
Cite as:
MUNIi003-A (RRID:CVCL_9S30)
Alternative name(s)
DMD03
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CENSOi003-B
(FB79R2c6, CENSOi258)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi005-A
(FB76R2c5, CENSOi245)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi007-A
(FB75R2c5, CENSOi255)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
MRIi027-A
(DMD 01)
Donor diseases:
Duchenne muscular dystrophy
CENSOi001-B
(FB78R2c2, CENSOi249)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
CENSOi002-B
(FB74R2c4, CENSOi261)
Donor's gene variants:
DMD, DMD
Donor diseases:
Duchenne muscular dystrophy
ICGi002-B
(DMD1_4)
Donor diseases:
Duchenne Muscular Dystrophy
ICGi002-C
(DMD1_11)
Donor diseases:
Duchenne Muscular Dystrophy
RGIe086-A
(SI-180)
Donor diseases:
Duchenne muscular dystrophy
ICGi002-A
(DMD1_1)
Donor diseases:
Duchenne Muscular Dystrophy
Last update 24th October 2019
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Masaryk University (MUNI)
Owner Petr Dvorak's Laboratory
Distributors
Derivation country Czech Republic

External Databases

Cellosaurus CVCL_9S30
BioSamples SAMEA5573703
Wikidata Q54907087

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 15-19
Ethnicity caucasian

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is affected.
Stage
immobile, non-sustained respirator need, cardiac manifestation
Synonyms
  • Muscular dystrophy, Duchenne
Family history no related to case
Is the medical history available upon request? rapid progression, mild cardiac phenotype
Is clinical information available? early onset of cardiac phenotype

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes
46, XY
Karyotyping method: G-Banding

External Databases (Donor)

BioSamples SAMEA5573704

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? No
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? Yes
Details on restriction to research project
Does consent permit unforeseen future research, without further consent? No
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? Yes
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Does consent expressly permit collection of genetic information? Yes
Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? Yes
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? Yes
Please describe how access is provided:
Does consent permit access to any other source of information about the clinical treatment or health of the donor? Yes
Contact data, institution, or website: Masaryk University, Pediatric Neurology Clinic
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Ethics Committee, Medical faculty, Masaryk University
Approval number 13/2012
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Ethics Committee, Medical faculty, Masaryk University
Approval number 13/2012
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? Life Technologies
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
Synonyms
  • Arm skin
Source cell origin
A zone of skin that is part of a leg [Automatically generated definition].
Synonyms
  • leg skin
  • leg zone of skin
  • zone of skin of leg
Age of donor (at collection) 15-19
Collected in 2013
Passage number reprogrammed 3

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Selection criteria for clones morphology, alcaline phophatase, SSEA, Oct4, Nanog
Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Gelatin
Feeder cells mouse embryonic fibroblast
Cellfinder Ont Id: EFO_0004040
Passage method Mechanically
O2 Concentration 20 %
CO2 Concentration 5 %
Medium Other medium:
Base medium: Dulbecco`s modified Eagle medium (DMEM)/F12
Main protein source: Knock-out serum replacement
Serum concentration: 15 %
Supplements
penicillin-streptomycin 0,5 %
MEM Non-essential Amino Acids 1 %
human FGF2 4 ng/ml

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Alkaline Phosphatase
Yes
NANOG
Yes
POU5F1 (OCT-4)
Yes
SSEA-3
Yes
TRA 1-81
Yes
Differentiation Potency
Cardiac Myocyte
Ont Id: FMA_14067
In vitro spontaneous differentiation
In vitro directed differentiation
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Passage number: 58

Other Genotyping (Cell Line)